MDCG guidance

Conformity assessment procedures for 3D printing and 3D printed products to be used in a medical context for COVID-19

MDCG guidance · COVID-19 · April 2020

Key facts

Reference Conformity assessment procedures for 3D printing and 3D printed products to be used in a medical context for COVID-19
Title Conformity assessment procedures for 3D printing and 3D printed products to be used in a medical context for COVID-19
Topic COVID-19
Published April 2020
Document health.ec.europa.eu

At a glance

  • Yes Full text searchable in Orca1
  • Conformity assessment procedures for 3D printing and 3D printed products to be used in a medical context for COVID-19 Revisions on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About MDCG guidance documents

The Medical Device Coordination Group (MDCG), made up of EU member-state experts, endorses guidance on applying the Medical Devices Regulation (EU) 2017/745 and the In Vitro Diagnostic Regulation (EU) 2017/746. Each page here covers one document and all of its revisions.

Source: European Commission, Medical Device Coordination Group (MDCG) endorsed documents and other guidance. © European Union, reused under Commission Decision 2011/833/EU

Browse all MDCG guidance documents